|Flow Cytometry (Flow)||Assay Dependent|
|Immunocytochemistry (ICC)||10 µg/ml|
|Immunofluorescence (IF)||10 µg/ml|
|Western Blot (WB)||1-3 µg/ml|
|Tested Species reactivity||Human, Mouse, Rat|
|Host / Isotype||Rat / IgG2a|
|Immunogen||Synthetic peptide corresponding to residues R(196) G Q S C N N Q P L N H K V Y M R N S K Y P E D L(220) of mouse Fas Ligand.|
|Purification||Size-exclusion - Gel filtration|
|Contains||0.02% sodium azide|
|Storage conditions||Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.|
MA1-25850 has been successfully used in immunocytochemistry, FACS and Western blot procedures.
The MA1-25850 immunogen is a synthetic peptide corresponding to residues R(196) G Q S C N N Q P L N H K V Y M R N S K Y P E D L(220) of mouse Fas Ligand.
Fas / APO1 (CD95) is an important member of the tumour necrosis factor (TNF) superfamily involved in membrane-mediated apoptosis. Ligation of Fas by Fas Ligand or an anti-Fas cross-linking antibody, triggers activation of the caspase cascade. Functional impairment of the Fas / Fas Ligand system is associated with the development and progression of malignancies. Fas gene mutations have been suggested to have a role in testicular germ cell tumours. Tumour cells frequently exhibit de novo expression of Fas Ligand, which plays a significant role in local tissue destruction, metastatic spread, and immune escape of the tumor cells. The apoptosis of lymphocytes, which occurs in autoimmune diseases, is usually induced by the Fas/Fas Ligand system. Fas is believed to be involved in various autoimmune diseases including ulcerative colitis, Graves disease, and rheumatoid arthritis. Fas expression on gastric epithelial cells in patients infected with H. Pylori is responsible for the accelerated apoptosis of the cells. Serum Fas Ligand concentration has also been shown to be associated with atherosclerosis and inflammatory disease, in patients with hypertension.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: APO1; apoptosis (APO-1) antigen ligand 1; Apoptosis (APO-1) antigen ligand 1 (Fas antigen ligand); Apoptosis antigen ligand; apoptosis antigen ligand 1; APTL; CD178; CD95 ligand; CD95-L; CD95L; CD95L protein; Fas antigen ligand; Fas Ligand; Fas ligand (TNF superfamily, member 6); Fas-LG; FasL; generalized lymphoproliferative disease; mutant tumor necrosis factor family member 6; Tumor necrosis factor (ligand) superfamily member 6 (apoptosis (APO-1) antigen ligand 1) (Fas antigen ligand); Tumor necrosis factor (ligand) superfamily, member 6 (apoptosis (APO-1) antigen ligand 1) (Fas antigen ligand); tumor necrosis factor ligand 1A; Tumor necrosis factor ligand superfamily member 6
Gene Aliases: ALPS1B; APT1LG1; APTL; CD178; CD95-L; CD95L; Fas-L; FASL; FASLG; gld; TNFSF6; TNLG1A
If an Invitrogen™ antibody doesn’t perform as described on our website or datasheet, we’ll replace the product at no cost to you, or provide you with a credit for a future purchase.*
Get expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.